A comparison of the benefits of mitoxantrone and other recent therapeutic approaches in multiple sclerosis

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.5, Iss.4, 2004-04, pp. : 747-765

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The cardiac effects of mitoxantrone: do the benefits in multiple sclerosis outweigh the risks?

By Murray T Jock

Expert Opinion on Drug Safety, Vol. 5, Iss. 2, 2006-03 ,pp. : 265-274

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of mitoxantrone for the treatment of multiple sclerosis

By Jain K.K.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 5, 2000-05 ,pp. : 1139-1149

Informa Healthcare

Access to resources Recommend Favorite

Mitoxantrone: A Review of its Use in Multiple Sclerosis

By Scott L.J. Figgitt D.P.

CNS Drugs, Vol. 18, Iss. 6, 2004-01 ,pp. : 379-396

Adis International

Access to resources Recommend Favorite

Natalizumab: multiple benefits in multiple sclerosis

Inpharma, Vol. 1, Iss. 1487, 2005-01 ,pp. : 9-11

Adis International

Access to resources Recommend Favorite

Modern approaches to multiple sclerosis

By Wilson Martin

Clinical Medicine, Vol. 11, Iss. 4, 2011-08 ,pp. : 361-363

Royal College Of Physicians

Access to resources Recommend Favorite